Clinical Trial Update: PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 PK/PD study compares Gan & Lee's insulin glargine injection with Lantus for Type 1 diabetes, and the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Gan & Lee insulin glargine injection (insulin glargine)
• Lantus (insulin glargine)

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED